Robert Alexander - 15 May 2025 Form 4 Insider Report for Allakos Inc. (ALLK)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ALLK
Reported as of: 15 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 May 2025, 16:00:20 UTC
Prior SEC filing: 07 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ H. Baird Radford, III, by power of attorney

Key filing fact

Robert Alexander filed Form 4 for Allakos Inc. (ALLK) on 15 May 2025.

Key facts

This page summarizes Robert Alexander's Form 4 filing for Allakos Inc. (ALLK).
8 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 15 May 2025, 16:00.

Change

Previous filing in this sequence was filed on 07 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001608782 Primary reporting owner

Alexander Robert

Relationship: Chief Executive Officer, Director
Address: 149 COMMONWEALTH DR, SUITE 1090, MENLO PARK
Signature: /s/ H. Baird Radford, III, by power of attorney
Signature date: 15 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALLK transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -738,104
Change %: -100%
Price
Shares after: 0
Date: 15 May 2025
Ownership: Direct
Footnotes: F1, F2

ALLK transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -320,300
Change %: -100%
Price
Shares after: 0
Date: 15 May 2025
Ownership: See footnote
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALLK transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -912,500
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 912,500
Exercise price: $0.6900
Footnotes: F4

ALLK transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -290,022
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 290,022
Exercise price: $4.01
Footnotes: F4

ALLK transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -306,960
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 306,960
Exercise price: $4.31
Footnotes: F4

ALLK transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -250,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 250,000
Exercise price: $35.28
Footnotes: F4

ALLK transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -462,325
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 462,325
Exercise price: $7.20
Footnotes: F4

ALLK transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -2,000,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,000,000
Exercise price: $1.25
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Robert Alexander is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

Includes 292,810 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer.

Footnote F2

Disposed of pursuant to the terms of that certain Agreement and Plan of Merger, dated April 1, 2025, by and among the Issuer, Concentra Biosciences, LLC and Concentra Merger Sub III, Inc. (the "Merger Agreement") in exchange for $0.33 in cash per share.

Footnote F3

The shares are held by Mr. Alexander and Stacey Lee Alexander, as Trustees of the Alexander 2018 Irrevocable Descendants' Trust.

Footnote F4

This option was cancelled without consideration pursuant to the terms of the Merger Agreement.